Genetic variability in the renin-angiotensin system: Prevalence of alleles and genotypes

Journal of Cardiovascular Risk

Volumn 4, Issue 5, 1997, Pages 401-422

  Staessen, Jan A ^a   Ginocchio, Giuliana ^b   Wang, Ji Guang ^c   Saavedra, Arturo P ^a   Soubrier, Florent ^d   Vlietinck, Robert ^e   Fagard, Robert ^a  

^a KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

^b Center for Human GeneticsUniversity of Leuven   (Belgium)

^c UNIVERSITY OF PADOVA   (Italy)

^d FUWAI HOSPITAL   (China)

^e INSERM   (France)

Author keywords

Angiotensin II converting enzyme; Angiotensin II type I receptor; Angiotensinogen; Genetic polymorphism; Renin

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE;

EID: 0031407123     PISSN: 13506277     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043798-199710000-00013     Document Type: Article

References (267)

1. Samani NJ, Thompson JR, O’Toole L, Channer K, Woods KL: A metaanalysis of the association of the deletion allele of the angiotensinconverting enzyme with myocardial infarction. Circulation 1996, 94:708-712.
2. Marian AJ, Yu QT, Workman R, Greve G, Roberts R: Angiotensinconverting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993, 342:1085-1086.
3. Pfeufer A, Osterziel KJ, Urata H, Borck G, Schuster H, Wienker T, et al.: Angiotensin converting enzyme and chymase gene polymorphisms in hypertrophic cardiomyopathy. Am J Cardiol 1996, 78:362-364.
4. Danser AHJ, ten Cate FJ, Osterop APRM, Krams R, Derkx FHM, Schalekamp MADH: Lack of association between the insertion/deletion polymorphism of the ACE gene and hypertrophic cardiomyopathy. [Abstract]. J Hypertens 1996,14(suppl 1):S33.
5. Badenhop RF, Wang XL, Wilcken DEL: Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation 1995, 91:1655-1658.
6. Camblen F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveller D, et al.: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992, 359:641-644.
7. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, et al.: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994, 330:1629-1633.
8. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F: Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993, 290:33-40.
9. Gu XX, Spaepen M, Guo C, Fagard R, Amery A, Lijnen P, et al.: Lack of association between the I/D polymorphism of the angiotensinconverting enzyme gene and essential hypertension in a Belgian population. J Hum Hypertens 1994, 8:683-685.
10. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, et al.: Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994, 93:1285-1287.
11. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, et al.: The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 1993, 21:455-460.
12. Harden PN, Geddes C, Rowe PA, Mcllroy JH, Boulton-Jones M, Rodger RSC, et al.: Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 1995, 345:1540-1542.
13. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al.: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992, 71:169-180.
14. Iwai N, Ohmichi N, Nakamura Y, Mitsunami K, Kinoshita M: Molecular variants of the angiotensinogen gene and hypertension in a Japanese population. Hypertens Res 1994, 17:117-121.
15. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM: Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1992, 1:72-75.
16. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, et al.: Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995, 345:1600-1603.
17. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al.: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995, 332:706-711.
18. Mattu RK, Needham EWA, Galton DJ, Frangos E, Clark AJL, Caulfield M: A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation 1995, 91:270-274.
19. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, et al.: Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993, 342:1073-1075.
20. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin l-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343-1346.
21. Samani NJ, Martin DS, Brack M, Cullen J, Chauhan A, Lodwick D, et al.: Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty. Lancet 1995, 345:1013-1016.
22. Schmidt S, van Hooft IMS, Grobbee DE, Ganten D, Ritz E: Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. J Hypertens 1993, 11:345-348.
23. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, et al.: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994, 330:1634-1638.
24. Tiret L, Ricard S, Poirier O, Arveiler D, Cambou JP, Luc G, et al.: Genetic variation of the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM study. J Hypertens 1995, 13:311-317.
25. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, et al.: A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993, 4:59-61.
26. Arbustini E, Grasso M, Fasani R, Klersy C, Diegoli M, Porcu E, et al.: Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. Brit Heart J 1995, 74:584-591.
27. Dessl-Fulgheri P, Catalini R, Sarzani R, Sturbini S, Siragusa N, Guazzarotti F, et al.: Angiotensin converting enzyme gene polymorphism and carotid atherosclerosis in a low-risk population. J Hypertens 1995, 13:1593-1596.
28. Ueda S, Weir CJ, Inglis GC, Murray GD, Muir KW, Lees KR: Lack of association between angiotensin converting enzyme gene insertion/deletion polymorphism and stroke. J Hypertens 1995, 13:1597-1601.
29. Hingorani AD, Jia H, Stevens PA, Hopper R, Dickerson JEC, Brown MJ: Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens 1995, 13:1602-1609.
30. van Essen GG, Rensma PL, de Zeeuw D, Sluiter WJ, Scheffer H, Apperloo AJ, et al.: Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet 1996, 347:94-95.
31. Bloem LI, Manatunga AK, Pratt JH: Racial difference in the relationship of an angiotensin l-converting enzyme gene polymorphism to serum angiotensin l-converting enzyme activity. Hypertension 1996, 27:62-66.
32. Barley J, Blackwood A, Miller M, Markandu ND, Carter ND, Jeffery S, et al.: Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens 1996, 10:31-35.
33. Rotimi C, Puras A, Cooper R, McFarlane-Anderson N, Forrester T, Ogunbiyi O, et al.: Polymorphisms of renin-angiotensin genes among Nigerians, Jamaicans, and African Americans. Hypertension 1996, 27:558-563.
34. Hiraga H, Oshima T, Watanabe M, Ishida M, Ishida T, Shingu T, et al.: Angiotensin l-converting enzyme gene polymorphism and salt sensitivity in essential hypertension. Hypertension 1996, 27:569-572.
35. Dudley C, Keavney B, Casadei B, Conway J, Bird R, Ratcliffe P: Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of renin-angiotensin system genes. J Hypertens 1996, 14:259-262.
36. Barley J, Blackwood A, Carter ND, Crews DE, Cruickshank JK, Jeffery S, et al.: Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertens 1994, 12:955-957.
37. Bennett CL, Schrader AP, Morris BJ: Cross-sectional analysis of Met-235-Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Comm 1993, 197:833-839.
38. Bohn M, Berge KE, Bakken A, Erikssen J, Berg K: Insertion/deletion (I/D) polymorphism at the locus for angiotensin l-converting enzyme and myocardial infarction. Clin Genet 1993, 44:292-297.
39. Bonnardeaux A, Davies E, Jeunemaitre X, Féry I, Charru A, Clauser E, et al.: Angiotensin II type-1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994, 24:63-69.
40. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, et al.: Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994, 90:669-676.
41. Doria A, Onuma T, Gearin G, Freire MBS, Warram JH, Krolewski AS: Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes. Hypertension 1996, 27:1134-1139.
42. Duru K, Farrow S, Wang JM, Lockette W, Kurtz T: Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am J Hypertens 1994, 7:759-762.
43. Evans AE, Poirier O, Kee F, Lecerf L, McCrum E, Falconer T, et al.: Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. Q J Med 1994, 87:211-214.
44. Friedl W, Krempier F, Paulweber B, Pichler M, Sandhofer F: A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary heart disease in an Austrian population. Atherosclerosis 1995, 112:137-143.
45. Higashimori K, Zhao Y, Higaki J, Kamitani A, Katsuya T, Nakura J, et al.: Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Comm 1993, 191:399-404.
46. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M: DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994, 90:2622-2628.
47. Jeunemaitre X, Rigat B, Charru A, Houot AM, Soubrier F, Corvol P: Sib pair linkage analysis of renin gene haplotypes in human essential hypertension. Hum Genet 1992, 88:301-306.
48. Johnson AG, Simons LA, Friedlander Y, Simons J, Davis DR, MaCallum J: i/D polymorphism of the angiotensin-converting enzyme gene does not predict isolated systolic or systolic-diastolic hypertension in the elderly. J Hum Hypertens 1996, 10:167-169.
49. Kojima S, Inenaga T, Matsuoka H, Kuramochi M, Omae T, Nara Y, et al.: The association between salt sensitivity of blood pressure and some polymorphic factors. J Hypertens 1994, 12:797-801.
50. Lindpaintner K, Lee M, Larson MC, Rao VS, Pfeffer MA, Ordovas JM, et al.: Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 1996, 334:1023-1028.
51. Miettinen HE, Korpela K, Hamalainen L, Kontula K: Polymorphisms of the apolipoprotein and angiotensin converting enzyme genes in young North Karelian patients with coronary heart disease. Hum Genet 1994, 94:189-192.
52. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al.: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin l-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992, 51:197-205.
53. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, et al.: Synergistic effects of angiotensin-converting enzyme and angiotensin-ll type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994, 344:910-913.
54. Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A, et al.: Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993, 341:991-992.
55. Yorioka T, Suehiro T, Yasuoka N, Hashimoto K, Kawada M: Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA nephropathy. Clin Nephrol 1995, 44:80-85.
56. Zhao Y, Higashimori K, Higaki J, Kamitani A, Ohishi M, Katsuya T, et al.: Significance of the deletion polymorphism of the angiotensin converting enzyme gene as a risk factor for myocardial infarction in Japanese. Hypertens Res 1994, 17:55-57.
57. Ohishi M, Fujii K, Minamino T, Higaki J, Kamitani A, Rakugi H, et al.: A potent genetic risk factor for restenosis. Nat Genet 1993, 5:324-325.
58. Arngrimsson R, Purandare S, Connor M, Walker JJ, Bjornsson S, Soubrier F, et al.: Angiotensinogen; a candidate gene involved in preeclampsia? Nat Genet 1993, 4:114-115.
59. Benetos A, Gautier S, Ricard S, Tpouchian J, Asmar R, Poirier O, et al.: Influence of angiotensin converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 1996, 94:698-703.
60. Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen PJ: Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol 1994, 267:H1107-H1111.
61. Morise T, Takeuchi Y, Takeda R: Angiotensin-converting enzyme polymorphism and essential hypertension. Lancet 1994, 343:125.
62. Ohishi M, Rakugi H, Ogihara T: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994, 331:1097-1098.
63. Zingone A, Dominijanni A, Mele E, Marasco O, Melina F, Minchella P, et al.: Deletion polymorphism in the gene for angiotensin converting enzyme is associated with elevated fasting blood sugar levels. Hum Genet 1994, 94:207-209.
64. Soubrier F, Jeunemaitre X, Rigat B, Houot AM, Cambien F, Corvol P: Similar frequencies of renin gene restriction fragment length polymorphisms in hypertensive and normotensive subjects. Hypertension 1990, 16:712-717.
65. Castellano M, Mulesan ML, Rizzoni D, Beschi M, Pasini G, Cinelli A, et al.: Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in general population. The Vobarno study. Circulation 1995, 91:2721-2724.
66. Danser AHJ, Schalekamp MADH, Bax WA, Maassen van den Brink A, Saxena PR, Riegger GAJ, et al.: Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995, 92:1387-1388.
67. Benetos A, Topouchian J, Ricard S, Gautier S, Bonnardeaux A, Asmar R, et al.: Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension 1995, 26:44-47.
68. Morris BJ, Griffiths LR: Frequency in hypertensives of alleles for a RFLP associated with the renin gene. Biochem Biophys Res Comm 1988, 150:219-224.
69. Naftilan AJ, Williams R, Burt D, Paul M, Pratt RE, Hobart P, et at.: A lack of genetic linkage of renin gene restriction fragment length polymorphisms with human hypertension. Hypertension 1989, 14:614-618.
70. Berge KE, Berg K: No effect of insertion/deletion polymorphism at the ACE locus on normal blood pressure level or variability. Clin Genet 1994, 45:169-174.
71. Bebn M, Berge KE, Bakken A, Erikssen J, Berg K: insertion/deletion (I/D) polymorphism at the locus for angiotensin l-converting enzyme and parental history of myocardial infarction. Clin Genet 1993, 44:298-301.
72. Zee RYL, Lou YK, Griffiths LR, Morris BJ: Association of a polymorphism of the angiotensin l-converting enzyme gene with essential hypertension. Biochem Biophys Res Comm 1992, 184:9-15.
73. Morris BJ, Zee RYL, Schrader AP: Different frequencies of the angiotensin converting enzyme genotypes in older hypertensive individuals. J Clin Invest 1994, 94:1085-1089.
74. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallab M, et al.: Relationships between angiotensin l-converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994, 43:384-388.
75. Lachurte ML, Azizi M, Guyene TT, Alhenc-Gelas F, Ménard J: Angiotensinconverting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 1995, 91 2933-2942.
76. Ueda S, Elliott HL, Morton JJ, Connell JMC: Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 1995, 25:1266-1269.
77. Doria A, Warram JH, Krowelski AS: Genetic predisposition to diabetic nephropathy: evidence for a role of the angiotensin I converting enzyme gene. Diabetes 1994, 43:690-695.
78. Hegele RA, Brunt JH, Connell JMC: A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation 1994, 90:2207-2212.
79. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, et al.: Deletion polymorphism of the angiotensin l-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in Japanese. Circulation 1994, 90:2199-2202.
80. Forrester T, Cooper R, Bennet F, McFarlane-Anderson N, Puras A, Rotimi C, et al.: Angiotensinogen and blood pressure among blacks: findings from a community survey in Jamaica. J Hypertens 1995, 14:315-321.
81. Lee EJD: Population genetics of the angiotensin-converting enzyme in Chinese. Brit J Clin Pharmacol 1994, 37:212-214.
82. Ishigami T, Iwamoto T, Tamura K, Yamaguchi S, Iwasawa K, Uchino K, et al.: Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in Japan: ethnic difference of ACE genotype. Am J Hypertens 1995, 8:95-97.
83. Rutledge D, Browe C, Kubilis P, Ross E: Analysis of two variants of the angiotensinogen gene in essential hypertensive African-Americans. Am J Hypertens 1994, 7:651-654.
84. Kamdar S, Daniel H, Fogarty P, Lawson M, Munroe P, Caulfield M: ACE insertion/deletion polymorphism in Vincentian African Caribbeans with essential hypertension. [Abstract], J Hum Hypertens 1994, 8:611.
85. Ludwig E, Cornell PS, Anderson JL, Marshall HW, Lalouel JM, Ward RH: Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995, 91:2120-2124.
86. Rotimi C, Morrison L, Cooper R, Oyejlde C, Effiong E, Lapido M, et al.: Angiotensinogen gene in human hypertension: lack of an association of the 235T allele among African Americans. Hypertension 1994, 24:591-594.
87. Young RP, Sanderson JE, Tomlinson B, Woo KS, Critchley AJH: Angiotensin converting enzyme insertion-deletion polymorphism in Chinese. J Hypertens 1995, 13:1479-1483.
88. Kamitani A, Rakugi H, Higaki J, Yi Z, Mikami H, Miki T, et al.: Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens 1994, 8:521-524.
89. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen D: Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994, 91:3662-3665.
90. Harn HJ, Chang CY, Ho LI, Liu CA, Jeng JR, Lin FG, et al.: Evidence that the polymorphism of the angiotensin I converting enzyme gene may be related to idiopathic dilated cardiomyopathy in the Chinese population. Biochem Mol Biol Int 1995, 35:1175-1181.
91. Zee RYL, Ying LH, Griffiths LR, Morris BJ: Association and linkage analyses of restriction fragment length polymorphism for the human renin and antithrombin III genes in essential hypertension. J Hypertens 1991, 9:825-830.
92. Nomura H, Koni I, Michishita Y, Morise T, Takeda R: Angiotensinconverting enzyme gene polymorphism in haemodialysis patients. Lancet 1994, 343:482-483.
93. Schächter F, Faure-Delanef L, Guénot F, Rouger H, Froguel P, Lesueur-Ginot L, et al.: Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994, 6:29-32.
94. Gardemann A, Weiss T, Schwartz O, Eberbach A, Katz N, Hehrlein FW, et al.: Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary heart disease and myocardial infarction in iow-risk patients. Circulation 1995, 92:2796-2799.
95. Panahloo A, Andrés C, Mohamed-Ali V, Gould MM, Talmud P, Humphries SE, et al.: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Circulation 1995, 92:3390-3393.
96. Nakata Y, Katsuya T, Rakugi H, Takami S, Ohishi M, Kamino K, et al.: Polymorphism of the apolipoprotein E and angiotensin-converting enzyme genes in Japanese subjects with silent myocardial ischemia. Hypertension 1996, 27:1205-1209.
97. Schuster H, Wienker WF, Stremmler U, Noll B, Steinmetz A, Luft FC: An angiotensin-converting enzyme gene variant is associated with acute myocardial infarction in women, but not in men. Am J Cardiol 1995, 76:601-603.
98. Kaski JC, Zhang Y, Calvirto R, Vazquez-Rodriguez JM, Castro-Beiras A, Jeffery S, et al.: Angiotensin-converting enzyme insertion/deletion polymorphism and restenosis after coronary angioplasty in unstable angina pectoris. Am J Cardiol 1995, 77:875-879.
99. Zhang Y, Jeffery S, Barley J, Hann C, Carter N, Kaski JC: Angiotensinconverting enzyme insertion/deletion polymorphism in angina pectoris with normal coronary angiograms. Am J Cardiol 1996, 77:877-879.
100. Lechin M, Quiñones MA, Omran A, Hill R, Yu QT, Rakowski H, et al.: Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995, 92:1808-1812.
101. Takami S, Katsuya T, Higaki J, Rakugi H, Sato K, Nakata Y, et al.: A lack of cosegregation between angiotensin II receptor gene polymorphisms and hypertension. [Abstract]. J Hypertens 1996,14(suppi 1): S31.
102. Watanabe Y, Ishigami T, Iwamoto T, Tamura K, Yoshimura H, Sawada R, et al.: Association analysis of polymorphism for the angiotensin converting enzyme gene in patients with cerebral infarction in Japan. [Abstract]. J Hypertens 1996,14(suppl 1):S32.
103. Castellano M, Muiesan ML, Beschi M, Rizzoni D, Pasini G, Salvetti M, et al.: ACE insertion/deletion polymorphism is associated with carotid artery intima-media thickness, but not left ventricular mass, in a general population. [Abstract], J Hypertens 1996,14(suppl 1):S213.
104. Perticone F, Pugliese F, Ceravolo R, Cosco C, Trapasso MP, Perrotti N, et al.: Association of angiotensin converting enzyme gene with blood pressure variability and left ventricular mass. [Abstract]. J Hypertens 1996, 14(suppl 1):S30.
105. O’Kane KPJ, Mayet J, Thom S, Webb DJ: Left ventricular hypertrophy is independent of ACE genotype in untreated essential hypertension. [Abstract]. J Hypertens 1996,14(suppl 1):S31.
106. Miyamoto Y, Yoshimasa T, Itoh H, Igaki T, Harada M, Yamashita J, et al.: Association of angiotensin 11 type 1 receptor gene polymorphism with essential hypertension in Japanese. [Abstract]. J Hypertens 1996, 1 4(suppl 1):S29.
107. Clifford CP, Nunez DJR: Racial differences in the frequency of a restriction site polymorphism of the angiotensin converting enzyme (ACE) gene. [Abstract]. J Hypertens 1996,14(suppl 1):S13.
108. Jian M, Cao X, Huang J, Qi J, Liu G, Wang J, et al.: Polymorphism of angiotensin I converting enzyme gene in the older Chinese: linked to ambulatory blood pressure levels and circadian blood pressure rhythm. Int J Cardiol 1996, 55:33-40.
109. Sanderson JE, Young RP, Yu CM, Chan S, Critchley JAJH, Woo KS: Lack of association between insertion/deletion polymorphism of the angiotensin-converting enzyme gene and end-stage heart failure due to ischemic or idiopathic dilated cardiomyopathy in the Chinese. Am J Cardiol 1996, 77:1008-1010.
110. Montgomery HE, Keeling PJ, Goldman JH, Humphries SE, Talmud PJ, McKenna WJ: Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1995, 25:1627-1631.
111. Pinto YM, van Gilst WH, Kingma JH, Schunkert H, for the Captopril and Thrombolysis Study Investigators: Deletion-type allele of the angiotensinconverting enzyme gene is associated with progressive ventricular dilation after myocardial infarction. J Am Coll Cardiol 1995, 25:1622-1626.
112. Summers KM, West JA, Huggard PR, West MJ: Angiotensin converting enzyme and regulation of blood pressure in a large Australian family. Clin Exp Pharmacol Physiol 1993, 20:320-323.
113. Beohar N, Damaraju S, Prather A, Yu QT, Raizner AE, Kleiman NS, et al.: Angiotensin converting enzyme genotype DD is a risk factor for coronary heart disease. J Invest Med 1995, 43:275-280.
114. Doi Y, Yoshizumi H, Yoshinari M, Lino K, Yamamoto M, Ichikawa K, et al.: Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in the Japanese patients with NIDDM. Diabetologia 1996, 39:97-102.
115. Dudley CRK, Keavney B, Stratton IM, Turner RC, Ratcliffe PJ: U.K. Prospective Diabetes Study XV: relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 1995, 48:1907-1911.
116. Keavney BD, Dudley CRK, Stratton IM, Holman RR, Matthews DR, Ratcliffe PJ, et al.: UK Prospective Diabetes Study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM. Diabetologia 1995, 38:948-952.
117. Mizuiri S, Hemmi H, Inoue A, Yoshikawa H, Tanegashima M, Fushimi T, et al.: Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 1995, 70:455-459.
118. Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyazaki Y, Nagasawa R, et al.: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995, 96:2162-2169.
119. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, et al.: insertion/deletion polymorphism in the angiotensin-i-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 1995, 38:798-803.
120. Schmidt S, Schöne N, Ritz E, The Diabetic Nephropathy Study Group: Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 1995, 47:1176-1181.
121. Ukkola O, Savolainen MJ, Salmela PI, von Dickhoff K, Kiema T, Kesäniemi YA: Insertion/deletion polymorphism in the angiotensin-converting enzyme gene associated with macroangiopathy and blood pressure in patients with non-insulin-dependent diabetes mellitus. J Mol Med 1995, 73:307-311.
122. Pujia A, Gnasso A, Irace C, Dominijanni A, Zingone A, Perrotti N, et al.: Association between ACE-D/D polymorphism and hypertension in type II diabetic patients. J Hum Hypertens 1994, 8:687-691.
123. Talmud PJ, Watts GF, McBride S, Mandalia S, Brunt JNH, Coltart DJ, et al.: Angiotensin converting enzyme gene polymorphism and the course of angiographically defined coronary artery disease. Atherosclerosis 1995, 114:133-135.
124. Fujisawa T, Ikegami H, Shen GQ, Yamato E, Takekawa K, Nakagawa Y, et al.: Angiotensin-l-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995, 18:983-985.
125. Caulfield M, Lavender P, Newell-Price J, Farrall M, Kamdar S, Daniel H, et al.: Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995, 96:687-692.
126. Kamitani A, Rakugi H, Higaki J, Ohishi M, Shi SJ, Takami S, et al.: Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension 1995, 25:950-953.
127. Nishiuma S, Kario K, Kayaba K, Nagio N, Shimada K, Matsuo T, et al.: Effect of the angiotensinogen gene Met235-Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations. J Hypertens 1995, 13:717-722.
128. Dieguez-Lucena JL, Aranda-Lara P, Riuz-Galdön M, Garcia-Villanova J, Morell-Ocana M, Reyes-Engel A: Angiotensin l-converting enzyme genotypes and angiotensin II receptors. Response to therapy. Hypertension 1996, 28:98-103.
129. Winkelmann BR, Nauck M, Klein B, Russ AP, Böhm BO, Siekmeier R, et al.: Deletion polymorphism of the angiotensin l-converting enzyme is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk of myocardial infarction and coronary heart disease. Ann Intern Med 1996, 125:19-25.
130. Hamon M, Bauters C, Amant C, McFadden EP, Helbecque N, Lablanche JM, et al.: Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty. Circulation 1995, 92:296-299.
131. Gharavi AG, Lipkowitz MS, Diamond JA, Jhang JS, Phillips RA: Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension. Am J Cardiol 1996, 77:1315-1319.
132. Iwai N, Shimoike H, Ohmichi N, Kinoshita M: Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 1995, 25:688-693.
133. Ohmichi N, Iwai N, Nakamura Y, Kinoshita M: The genotype of the angiotensin-converting enzyme gene and global left ventricular dysfunction after myocardial infarction. Am J Cardiol 1995, 76:326-329.
134. Ohmichi N, Iwai N, Maeda K, Shimoike H, Nakamura Y, Izumi M, et al.: Genetic basis of left ventricular remodeling after myocardial infarction. Int J Cardiol 1996, 53:265-272.
135. Ishigami T, Umemura S, Iwamoto T, Tamura K, Hibi K, Yamaguchi S, et al.: Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation 1995, 91:951-954.
136. Kario K, Kanai N, Saito K, Nago N, Takefumi M, Shimada K: Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation 1996, 93:1630-1633.
137. Vassilikioti S, Doumas M, Douma S, Petidis K, Karagiannis A, Balaska K, et al.: Angiotensin converting enzyme gene polymorphism is not related to essential hypertension in a Greek population. Am J Hypertens 1996, 9:700-702.
138. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, et al.: Lack of relationship between an insertion/deletion polymorphism in the angiotensin l-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995, 44:489-494.
139. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Ricard S, et al: Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 1996, 45:367-369.
140. Fogarty DG, Hughes AE, Nevin NC, Doherty CC, Maxwell AP: Functional genetic markers of the renin-angiotensin system and the risk of diabetic retinopathy in insulin-dependent diabetes mellitus. [Abstract], J Am Soc Nephrol 1994, 5:376.
141. Prasad N, O’Kane KPJ, Johnstone HA, Wheeldon NM, McMahon AD, Webb DJ, et al: The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin-converting enzyme deletion allele. Q J Med 1994, 87:659-662.
142. West MJ, Summers KM, Burstow DJ, Wong KK, Huggard PR: Renin and angiotensin-converting enzyme genotypes in patients with essential hypertension and left ventricular hypertrophy. Clin Exp Pharmacol Physiol 1994, 21:207-210.
143. Rasmussen LM, Ledet T: Aortic atherosclerosis in diabetes mellitus is associated with insertion/deletion polymorphism in the angiotensin l-converting enzyme gene. No relation between polymorphism and aortic collagen content. Diabetologia 1996, 39:696-700.
144. Grim CE, Lifton RP, Wilson TW, Viswanathan A, Etienne C, Wilson DM, et al.: The angiotensinogen gene MT235 is not associated with blood pressure in blacks on Domenica. [Abstract]. Hypertension 1994, 24:381.
145. Kitamura H, Moriyama T, Izumi M, Yokoyama K, Yamauchi A, Ueda N, et al.: Angiotensin l-converting enzyme insertion/deletion polymorphism: potential significance in nephrology. Kidney Int 1996, 49(suppl 55):S101-S103.
146. Andersson B, Sylven C: The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure. J Am Coll Cardiol 1996, 28:162-167.
147. Parving HH, Jacobsen P, Tarnow L, Rossing P, Lecerf L, Poirier O, et al.: Deleterious effect of a deletion polymorphism in angiotensinconverting enzyme gene on progression of diabetic nephropathy during angiotensin-converting enzyme inhibition. Brit Med J 1996, 313:591-594.
148. Yoshida H, Kuriyama S, Atsumi Y, Tomonari H, Mitarai T, Hamaguchi A, et al.: Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 1996, 50:657-664.
149. Sharma P, Carter ND, Barley J, Brown MM: Molecular approach to assessing the genetic risk of cerebral infarction: deletion polymorphism in the gene encoding angiotensin 1-converting enzyme. J Hum Hypertens 1994, 8:645-648.
150. Wang XL, McCredie RM, Wilcken DEL: Genotype distribution of angiotensin-converting enzyme polymorphism in Australian healthy and coronary populations and relevance to myocardial Infarction and coronary heart disease. Arterioscler Thromb Vasc Biol 1996, 16:115-119.
151. Missouris CG, Barley J, Jeffery S, Carter ND, Singer DRJ, MacGregor GA: Genetic risk for renal artery stenosis: association with deletion polymorphism in angiotensin 1-converting enzyme gene. Kidney Int 1996, 49:534-537.
152. Leatham E, Barley J, Redwood S, Hussein W, Carter N, Jeffery S, et al.: Angiotensin-1 converting enzyme (ACE) polymorphism in patients presenting with myocardial infarction or unstable angina. J Hum Hypertens 1994, 8:635-638.
153. Sharma P, Carter ND, Barley J, Lunt R, Seymour CA, Brown MM: Polymorphisms in the gene encoding angiotensin 1-converting enzyme and the relationship to its post-translational product in cerebral infarction. J Hum Hypertens 1994, 8:633-634.
154. Schmidt S, Giessel R, Bergis KH, Strojek K, Grzeszczak W, Ganten D, et al.: Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. Nephrol Dial Transplant 1996, 11:1755-1761.
155. Schmidt S, Sharma AM, Zilch O, Beige J, Walla-Friedel M, Ganten D, et al.: Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset. Nephrol Dial Transplant 1995, 10:1145-1148.
156. Beige J, Weber A, Engeli S, Offerman G, Distler A, Sharma AM: Angiotensinogen-M235T genotype and post-transplant hypertension. Nephrol Dial Transplant 1996, 11:1538-1541.
157. Markus HS, Barley J, Lunt R, Bland JM, Jeffery S, Carter ND, et al.: Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke 1995, 26:1329-1333.
158. Barley J, Blackwood A, Sagnella G, Markandu N, MacGregor G, Carter N: Angiotensinogen Met235-Thr polymorphism in a London normotensive and hypertensive black and white population. J Hum Hypertens 1994, 8:639-640.
159. Celermajer DS, Sorensen KE, Barley J, Jeffrey S, Carter N, Deanfield J: Angiotensin-converting enzyme genotype is not associated with endothelial dysfunction in subjects without other coronary risk factors. Atherosclerosis 1994, 111:121-126.
160. Hunley TE, Julian BA, Phillips JA, III, Summar ML, Yoshida H, Horn RG, et al.: Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 1996, 49:571-577.
161. Schmidt S, Stier E, Hartung R, Stein G, Bahnisch J, Woodroffe AJ, et al.: No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. Am J Kidney Dis 1995, 26:727-731.
162. Samani NJ, O’Toole L, Martin D, Rai H, Fletcher S, Lodwick D, et al.: Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction. J Am Coll Cardiol 1996, 28:338-344.
163. Oike Y, Hata A, Ogata Y, Numata Y, Shido K, Kondo K: Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm: implications in the pathogenesis of myocardial infarction. J Clin Invest 1995, 96:2975-2979.
164. Jeunemaitre X, Charru A, Chatellier G, Dumont C, Sassano P, Soubrier F, et al.: M235T variant of the human angiotensinogen gene in unselected hypertensive patients. [Abstract]. J Hypertens 1993,11 (suppl 5):S80-S81.
165. McLaughlin KJ, Jagger C, Small M, Jardine AG: Effect of angiotensinogen gene T235 variant on the development of diabetic complications in type II diabetes mellitus. Lancet 1995, 346:1160.
166. Rutledge DR, Browe CS, Ross EA: Frequencies of the angiotensinogen gene and angiotensin I converting anzyme (ACE) gene in African Americans. Biochem Mol Biol Int 1994, 34:1271-1275.
167. Barley J, Carter ND, Cruickshank JK: Renin and atrial natriuretic peptide restriction fragment length polymorphisms: associations with ethnicity and blood pressure. J Hypertens 1991, 9:993-996.
168. Wierzbicki AS, Nimmo L, Feher MD, Cox A, Foxton J, Lant AF: Association of angiotensin converting enzyme DD genotype with hypertension in diabetes. J Hum Hypertens 1995, 9:671-673.
169. Suzuki T, Yokota H, Yamazaki T, Kitamura K, Yamaoki K, Nagai R, et al.: Angiotensin converting enzyme polymorphism is associated with severity of coronary heart disease and serum lipids (total cholesterol and triglycerides levels) in Japanese patients. Coronary Artery Dis 1996, 7:371-375.
170. McKenzie CA, Julier C, Forrester T, McFarlane-Anderson N, Keavney B, Lathrop GM, et al.: Segregation and linkage analysis of serum angiotensin l-converting enzyme levels: evidence for two quantitative-trait loci. Am J Hum Genei 1995, 57:1426-1435.
171. Chowdhury TA, Dronsfield MJ, Kumar S, Gough SLC, Gibson SP, Khatoon A, et al.: Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with diabetic nephropathy in IDDM. Diabetologia 1996, 39:1108-1114.
172. Ahnve S, Flodin T, Berglund L, Eggertsen G, Sylven C: Angiotensin converting enzyme gene polymorphism in acute myocardial infarction patients. [Abstract]. J Am Coll Cardiol 1995, 25:276A-277A.
173. Hosoi M, Nishizawa Y, Kogawa K, Kawagishi T, Konishi T, Maekawa K, et al.: Angiotensin-converting enzyme gene is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients. Circulation 1996, 94:704-707.
174. Fogarty DG, Harron JC, Hughes AE, Nevin NC, Doherty CC, Maxwell AP: A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 1996, 45:1204-1208.
175. Fornage M, Turner ST, Sing CF, Boerwinkle E: Variation at the M235T locus of the angiotensinogen gene and essential hypertension: a population-based case-control study from Rochester, Minnesota. Hum Genet 1995, 96:295-300.
176. Johnson AG, Simons LA, Friedlander Y, Simons J, Davis DR, MaCallum J: M235-T polymorphism of the angiotensonogen gene predicts hypertension in the elderly. J Hypertens 1996, 14:1061-1065.
177. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Ricard S, et al.: Angiotensin-I I type 1 receptor gene polymorphism and diabetic microangiopathy. Nephrol Dial Transplant 1996, 11:1019-1023.
178. Kauma H, Päivänsalo M, Savolainen MJ, Rantala AO, Kiema TR, Lilja M, et al.: Association between angiotensin converting enzyme gene and polymorphism and carotid atherosclerosis. J Hypertens 1996, 14:1183-1187.
179. Castellano M, Muiesan ML, Beschi M, Rizzoni D, Cinelli A, Salvetti M, et al.: Angiotensin II type 1 receptor A/C1166 polymorphism. Relationships with blood pressure and cardiovascular structure. Hypertension 1996, 28:1076-1080.
180. Popov V, Fomicheva E, Kovalev J, Schwartz E: Absence of association between the angiotensin-converting enzyme gene polymorphism and borderline hypertension in men of St Petersburg, Russia. J Hum Hypertens 1996, 10:557-559.
181. Hingorani AD, Sharma P, Jia H, Hopper R, Brown MJ: Blood pressure and the M235T polymorphism of the angiotensiongen gene. Hypertension 1996, 28:907-911.
182. McLaughlin KJ, Harden PN, Ueda S, Boulton-Jones JM, Connell JMC, Jardine AG: The role of genetic polymorphisms of the angiotensinconverting enzyme in the progression of renal diseases. Hypertension 1996, 28:912-915.
183. Hopkins PN, Lifton RP, Hollenberg NK, Jeunemaitre X, Hallouin MC, Skippin J, et al.: Blunted renal vascular response to angiotensin II is associated with a common variant of angiotensinogen and obesity. J Hypertens 1996, 14:199-207.
184. Yamakawa-Kobayashi K, Arinami T, Hamaguchi H: Absence of association of angiotensinogen gene T235 aliele with increased risk of coronary heart disease in Japanese. Lancet 1995, 346:515.
185. Kiema TR, Kauma H, Rantala AO, Lilja M, Reunanen A, Kesäniemi YA, et al.: Variation in angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension 1996, 28:1070-1075.
186. Caulfield M, Lavender P, Newell-Price J, Kamdar S, Farrall M, Clark AJL: Angiotensinogen in human essential hypertension. Hypertension 1996, 28:1123-1125.
187. Benetos A, Cambien F, Gautier S, Ricard S, Safar M, Laurent S, et al.: Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals. Hypertension 1996, 28:1081-1084.
188. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992, 20:1433.
189. Furuta H, Guo DF, Inigami T: Molecular cloning and sequencing of the gene encoding human angiotensin II type I receptor. Biochem Biophys Res Comm 1992, 183:8-13.
190. Stewart LA, Clarke MJ: Practical methodology of meta-analyses (overviews) using updated individual patient data. Stat Med 1996, 14:2057-2079.
191. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR: Publication bias in clinical research. Lancet 1991, 337:867-872.
192. Ravnskov U: Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. Brit Med J 1992, 305:15-19.
193. Shanmugan V, Sell KW, Saha BK: Mistyping ACE heterozygotes. PCR Methods Appl 1993, 3:120-121.
194. Kotelevtsev YV, Clauser E, Corvol P, Soubrier F: Dinucleotide repeat polymorphism in the human angiotensinogen gene. Nucleic Acids Res 1991,19:6978.
195. Fogarty DG, Maxwell AP, Doherty CC, Hughes AE, Nevin NC: ACE gene typing. Lancet 1994, 343:851-852.
196. Russ S, Maerz W, Ruzicka V, Stein U, Gross W: Rapid detection of the hypertension assiated Met-235-Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993, 2:609-610.
197. Khoury MJ, Beaty TH, Cohen BH: Fundamentals of Genetic Epidemiology, Oxford, UK: Oxford University Press; 1993.
198. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, et al.: The deletion/insertion polymorphism of the converting-enzyme and cardiovascular-renal risk. J Hypertens 1997, 15:1579-1592.
199. Sasaki M, Oki T, Luchi A, Tabata T, Yamada H, Manabe K, et al.: Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode amd pulsed Doppler echocardiographic studies. J Hypertens 1996, 14:1403-1408.
200. Tunny TJ, Xu L, Richardson KA, Stowasser M, Gartside M, Gordon RD: Insertion/deletion polymorphism of the angiotensin-converting enzyme gene and loss of the insertion allele in aldosterone-producing adenoma. J Hum Hypertens 1997, 10:827-830.
201. Chiang FT, Chern TH, Lai ZP, Tseng CD, Hsu KL, Lo HM, et al.: Age- and gender-dependent association of the angiotensin-converting enzyme gene with essential hypertension in a Chinese population. J Hum Hypertens 1997, 10:823-826.
202. Beige J, Zilch O, Hohenbleicher H, Ringel J, Kunz R, Distler A, et al.: Genetic variants of the renin-angiotensin system and the ambulatory blood pressure in essential hypertension. J Hypertens 1997, 15:503-508.
203. Cooper R, McFarlane-Anderson N, Bennett FI, Wilks R, Puras A, Tewksbury D, et al.: ACE, angiotensinogen and obesity: a potential way leading to hypertension. J Hum Hypertens 1997, 11:107-111.
204. Rotimi C, Cooper R, Ogunbiyi O, Morrison L, Lapido M, Tewksbury D, et al.: Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. Circulation 1997, 95:2348-2350.
205. Lesage S, Velho G, Vionnet N, Chatelain N, Demenais F, Passa P, et al.: Genetic studies of the renin-angiotensin system in arterial hypertension associated with non-insulin dependent diabetes mellitus. J Hypertens 1997, 15:601-606.
206. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Sorensen TIA, Jensen G, Tybjserg-Hansen A: ACE gene polymorphism: ischemic heart disease and longevity in 10150 individuals. A case referent and retrospective study based on the Copenhagen City Heart Study. Circulation 1997, 95:2358-2367.
207. Gharavi AG, Lipkowitz MS, Diamond JA, Chamie R, Phillips RA: Ambulatory blood pressure monitoring for detecting the relation between angiotensinogen gene polymorphism and hypertension. Am J Hypertens 1997, 10:687-691.
208. Hamon M, Amant C, Bauters C, Richard J, Helbecque N, Me Fadden E, et al.: Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries. Heart 1997, 77:502-505.
209. Maeda Y, Ikeda U, Ebata H, Hojo Y, Selno Y, Nakagami H, et al.: Angiotensin converting enzyme gene and polymorphism in essential hypertension based on ambulatory blood pressure monitoring. Am J Hypertens 1997, 10:786-789.
210. Kimura M, Yokota M, Fujimura T, Kato S, Hirayama H, Tsunekawa A, et al.: Associacion of a deletion polymorphism of the angiotensin-converting enzyme gene with left-ventricular hypertrophy in Japanese women with essential hypertension; multicenter study of 1, 919 subjects. Cardiology 1997, 88:309-314.
211. Tokgozoglu SL, Alikaslfoglu M, Atalar E, Tuncbilek E, Ovunc K, Aksoyek S, et al.: Angiotensin converting enzyme gene polimorphism and the risk and extent of ischemic heart disease among Turkish patients. Coronary Artery Dis 1997, 8:137-141.
212. Amant C, Bauters C, Bodart JC, Lablanche JM, Grollier G, Danchin N, et al.: D allele of the angiotensin l-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation 1997, 96:56-60.
213. Hegele RA, Harris SB, Hanley AJG, Sun F, Connelly PW, Zlnman B: Angiotensinogen gene variation associated with variation in blood pressure in a boriginal Canadians. Hypertension 1997, 29:1073-1077.
214. Ko YL, Ko YS, Wang SM, Chu PH, Teng MS, Cheng NJ, et al.: Angiotensinogen and angiotensin-l converting enzyme gene polymorphisms and the risk of coronary artery disease in Chinese. Hum Genet 1997, 100:210-214.
215. Corbo RN, Vilardo T, Mantuano E, Ruggeri M, Gemma AT, Scacchi R: Apolipoproteins B and E, and angiotensin l-converting enzyme (ACE) genetic polymorphisms in Italian women with coronary artery disease (CAD) and their relationships with plasma lipid and apolipoprotein levels. Clin Genet 1997, 52:77-82.
216. Berge KE, Bakken A, Bohn M, Erlkssen J, Berg K: A DNA polymorphism at the angiotensin II type I receptor (AT1R) locus and myocardial infarction. Clin Genet 1997, 52:71-76.
217. Jeunemaitre X, Ledru F, Battaglia S, Guillanneuf MT, Courbon D, Dumont C, et al.: Genetic polymorphisms of the renin-angiotensin system and angiographic extend and severity of coronary artery disease: the CORGENE study. Hum Genet 1997, 99:66-73.
218. Ludwig EH, Borecki IB, Ellison RC, Folsom AR, Heiss G, Higgins M, et al.: Associations between candidate loci angiotensin-converting enzyme and angiotesinogen with coronary heart disease and myocardial infarction: the NHLBI Family Heart Study. Ann Epidemiol 1997, 7:3-12.
219. Borecki IB, Province MA, Ludwig EH, Ellison RC, Folsom AR, Heiss G, et al.: Associations of candidate loci angiotensinogen and angiotensin-converting enzyme with severe hypertension: the NHLBI Family Heart Study. Ann Epidemiol 1997, 7:13-21.
220. Chiu KC, McCarthy JE: The insertion allele at the angiotensin I-converting enzyme gene locus is associated with insulin resistance. Metabolism 1997, 46:395-399.
221. Uemasu J, Nakaoka A, Kawasaki H, Ishikawa H, Yoshino Y, Shio H, et al.: Association between angiotensin converting enzyme gene polymorphism and clinical features in autosomal dominant polycystic kidney disease. Life Sci 1997, 60:2139-2144.
222. Amant C, Hamon M, Bauters C, Richard F, Helbecque N, McFadden EP, et al.: The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction. J Am Coll Cardiol 1997, 29:486-490.
223. Petricone F, Ceravolo R, Cosco C, Trapasso M, Zlngone A, Malatesta P, et al.: Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in Southern Italian patients. J Am Coll Cardiol 1997, 29:365-369.
224. Kario K, Kanai N, Nishiuma S, Fujii T, Saito K, Matsuo T, et al.: Hypertensive nephropathy and the gene for angiotensin-converting enzyme. Arterioscler Thromb Vase Biol 1997, 17:252-256.
225. Ringel J, Beige J, Kunz R, Distler A, Sharma AM: Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension. Diabetologia 1997, 40:193-199.
226. Miller JA, Scholey JW, Thai K, Pei Y: Angiotensin converting enzyme gene polymorphism and renal hemodynamic function in early diabetes. Kidney Int 1997, 51:119-124.
227. Watanabe Y, Ishigami T, Kawano Y, Umahara T, Nakamori A, Mizushima S, et al.: Angiotensin-converting enzyme gene I/D polymorphism and carotid plaques in Japanese. Hypertension 1997, 30:569-573.
228. Hibi K, Ishigami T, Kimura K, Nakao M, Iwamoto T, Tamura K, et al.: Angiotensin-converting enzyme gene polymorphism adds risk for the severity of coronary atherosclerosis in smokers. Hypertension 1997, 30 (part 2):574-579.
229. Sato N, Katsuya T, Rakugi H, Takami S, Nakata Y, Mikl T, et al.: Association of variants in critical core promoter element of angiotensinogen gene with increased risk of essential hypertension in Japanese. Hypertension 1997, 30:321-325.
230. Atwood LD, Kammerer CM, Samollow PB, Hixson JE, Shade RE, MacCluer JW: Linkage of essential hypertension to the angiotensinogen locus in Mexican Americans. Hypertension 1997, 30:326-330.
231. Jeng JR, Shieh SM, Ham HJ, Lee MMS, Sheu WHH, Jeng CY: Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with hypertension. J Hypertens 1997, 15:963-968.
232. Clarkson PBM, Prasad N, MacLeod C, Burchell B, MacDonald TM: Influence of the angiotensin converting enzyme I/D gene polymorphisms on left ventricular diastolic filling in patients with essential hypertension. J Hypertens 1997, 15:995-1000.
233. Yamada Y, Ichihara S, Fujimura T, Yokota M: Lack of association of polymorphisms of the angiotensin converting enzyme and angiotensinogen genes with nonfamiiial hypertrophic or dilated cardiomyopathy. Am J Hypertens 1997, 10:921-928.
234. Ohmichi N, Iwai N, Uchida Y, Shichiri G, Nakamura Y, Kinoshita A: Relationship between the response to the angiotensin converting enzyme inhibitor imidapril and the angiotensin converting enzyme genotype. Am J Hypertens 1997, 10:951-955.
235. Nakano Y, Oshima T, Watanabe M, Matsuura H, Kajiyama G, Kambe M: Angiotensin l-converting enzyme gene polymorphism and acute response to captopril in essential hypertension. Am J Hypertens 1997, 10:1064-1068.
236. Kreutz R, Hübner N, Ganten D, Lindpaintner K: Genetic linkage of the ACE gene to plasma angiotensin-converting enzyme activity but not to blood pressure. A quantitative trait locus confers identical phenotypes in human and rat hypertension. Circulation 1995, 91:2381-2384.
237. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, et al:. Contribution of genetic polymorphisms in the renin-angiotensin system to the development of renal complications in insulindependent diabetes. Génétique de la Néphropathie Diabétique (GENEDIAB) Study Group. J Clin Invest 1997, 99:1585-1595.
238. Rotimi CN, Cooper RS, Ward RH, Morrison L: The role of the angiotensinogen gene in human hypertension: absence of an association among African Americans. [Abstract]. Genet Epidemiol 1996,10:339.
239. Litton RP, Warnock D, Acton RT, Harman L, Lalouel JM: High prevalence of hypertension-associated angiotensinogen variant T235 in African Americans. [Abstract], Clin Res 1993, 41:260A.
240. Johnson AG, Simons LA, Friedlander Y, Simons J, Davis D, MaCallum J: Polymorphism of the angiotensinogen but not the angiotensin converting enzyme gene predicts hypertension in the elderly. [Abstract]. J Hypertens 1996,14(suppl 1):S29.
241. Schmidt S, Giessel R, Bergis KH, Strojek K, Grzeszczak W, Ganten D, et al.: Association of the angiotensinogen gene M235T polymorphism with hypertension but not with diabetic nephropathy. [Abstract]. Kidney Blood Press Res 1996,19:49.
242. Lu S, Pershadsingh H, Purcell T, Wong A, Spence MA, Flodman P, et al.: Cross-sectional analysis of angiotensinogen genotypes and blood pressure in Mexican Americans. [Abstract]. Hypertension 1994, 24:381.
243. Iwai N, Kinoshita M: Molecular variant of angiotensinogen gene and essential hypertension in Japanese. [Abstract]. Hypertension 1994, 24:381.
244. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, et al.: A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997, 99:1786-1797.
245. M’Buyamba-Kabangu JR, Amery A, Lijnen P: Differences between black and white persons in blood pressure and related biological variables. J Hum Hypertens 1994, 8:163-170.
246. Berenson GS, Webber LS, Srinivasan SR, Cresanta JL, Frank GC, Farris RP: Black-white contrasts as determinants of cardiovascular risk in childhood: precursors of coronary heart disease and primary hypertensive diseases. Am Heart J 1984,108:672-683.
247. Dustan HP: Growth factors and racial differences In severity of hypertension and renal diseases. Lancet 1992, 339:1339-1340.
248. Hammond IW, Devereux RB, Alderman MH, Lutas EM, Spitzer MC, Crowley JS, et al.: The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 1986, 7:639-650.
249. Caplan LR: Strokes In African-Americans. Circulation 1991, 33:1469-1471.
250. Zhang XH, Sasaki S, Kesteloot H: Changes in the sex ratio of stroke mortality in the period of 1955 through 1990. Stroke 1995, 26:1774-1780.
251. Neel JV: Diabetes mellitus: a “thrifty” gene genotype rendered detrimental by “progress”? Am J Hum Genet 1962, 14:353-362.
252. Blackburn H, Prineas R: Diet and hypertension: anthropology, epidemiology and public health implications. Progr Biochem Pharmacol 1983, 19:31-79.
253. Wilson TW, Grim CE: Biohistory of slavery and blood pressure differences in blacks today. A hypothesis. Hypertension 1991,17(suppl 0:1-122-1-128.
254. Poulter NR, Khaw KT, Hopwood BEC, Mugambi M, Peart WS, Rose G, et al.: The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. Brit Med J 1990, 300:967-972.
255. Fagard R, Brguljan J, Staessen J, Thijs L, Derom C, Thomis M, et al.: Heritability of conventional and ambulatory blood pressures. A study in twins. Hypertension 1995, 26:919-924.
256. Schunkert H, Hense HW, Muscholl M, Luchner A, Riegger GAJ: Association of angiotensin converting enzyme and arterial blood pressure in a population-based sample. J Hypertens 1996, 14:571-576.
257. McGeer EG, Singh EA: Angiotensin-converting enzyme in cortical tissue in Alzheimer’s and some other neurological diseases. Dementia 1996, 3:299-303.
258. Azizi M, Rousseau A, Ezan E, Guyene TT, Michelet S, Grognet JM, et al.: Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator A/-Acetyl-Seryl-Aspartyl-Lysyl-Proline. J Clin Invest 1996, 97:839-844.
259. Robinson S, Lenfant M, Wdziecaczk-Bakala J, Melville J, Riches A: The mechanism of action of the tetrapeptide Acetyl-W-Ser-Asp-Lys-Pro (AcSDKP) in the control of haematopoietic stem cell proliferation. Cell Prolif 1992, 25:623-632.
260. Bonner G: Do kinins play a significant role in the antihypertensive and cardioprotective effects of angiotensin l-converting enzyme inhibitors? In Hypertension. Pathophysiology, Diagnosis and Management, 2nd edn. Edited by Laragh JH, Brenner BM. New York, USA: Raven Press; 1995:2877-2893.
261. Jorgensen JOL, Christiansen JS: Brave new senescence: GH therapy in adults. Lancet 1993, 341:1247-1248.
262. Griffiths LR, Board PG, Zwi MB, Morris BJ, McLeod JG, Nicholson GA: The B subunit of coagulation factor VIII is linked to renin and the Duffy blood group to a-spectrin on human chromosome 1. Hum Hered 1989, 39:107-109.
263. Gaillard I, Mattei MG, Clauser E, Corvol P: Assignment by in situ hybridization of the angiotensinogen gene to chromosome band 1 q4, the same region as the human renine gene. Hum Genet 1990, 84:341-343.
264. Curnow KM, Pascoe L, White PC: Genetic analysis of the human type-l angiotensin II receptor. Mol Endocrinol 1992, 6:1113-1118.
265. Perna NT, Batzer MA, Deininger PL, Stoneking M: Alu insertion polymorphism: a new type of marker for human population studies. Hum Biol 1992, 64:641-648.
266. Ji W, Zhang XY, Warshaman GS, Qu GZ, Ehrlich M: Effect of internal direct and indirect Alu repeat sequences on PCR. PCR Methods Appl 1994, 4:109-116.
267. Wierzbicki AS, Nimmo L, Lambert M: Ambiguities in angiotensin-converting-enzyme allele genotyping: a comparison of three methods. J Hum Hypertens 1997, 11:467-468.